PhD, Pharmacogenetics
University of Lausanne, Lausanne, Switzerland
MPH, School of Life Sciences
Pompeu Fabra University, Barcelona, Spain
PharmMSc, School of Pharmacy
University of Barcelona, Barcelona, Spain
Núria Saigi-Morgui, PhD, is a Research Epidemiologist at RTI-HS. She holds a doctorate in pharmacogenetics from Lausanne University (Switzerland), a master's degree in public health, with a focus on epidemiology and biostatistics from the Pompeu Fabra University (Barcelona), and a master's degree in pharmacy from Barcelona University. Dr. Saigi-Morgui's doctoral research focused on the evaluation of the metabolic side effects and pharmacogenetics of psychotropic treatments through an observational clinical study that involved coordination of a multidisciplinary team, patient recruitment, and data collection. She also acquired experience in designing and re-adapting study protocol according to guidelines and ethics committee requirements. Previously, Dr. Saigi-Morgui served as a research assistant with the World Health Organization, performing review and analysis of tuberculosis financing across low and middle income countries in Europe; and during an internship on Epidemiology at the Barcelona Public Health Institute, she investigated the profile of injection drug users and access to health services in Spain, gaining experience in cross-sectional studies. Other previous work involved monitoring the use of medicines and pharmaceutical devices, focusing on pharmacoeconomic purposes. She has over10 years of experience in multisite clinical research studies. In her current position, she coordinates and manages study implementation, data collection and management, quality control, and validation activities. She actively participates in writing study progress reports and memos for both clients and regulatory authorities and contributes to validation and dissemination activities.